Influenseg
NDC 75053-0011, Galphimia Glauca, Causticum, Eupatorium Perfoliatum, Ipecacuanha, Aconitum Napellus, Kali Bichromicum, Avena Sativa, Influenzinum (2021-2022), Lobelia Purpurescens, Anas Barbariae, Hepatis ET Cordis Extractum, Echinacea (Angustifolia), Canchalagua, liquid, from Nucleic Products, LLC.
- Product NDC
- 75053-0011
- Status
- Listed
- Labeler
- Nucleic Products, LLC
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75053-0011 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GALPHIMIA GLAUCA FLOWERING TOP4 [hp_X]/mL
- CAUSTICUM6 [hp_X]/mL
- EUPATORIUM PERFOLIATUM FLOWERING TOP6 [hp_X]/mL
- IPECAC6 [hp_X]/mL
- ACONITUM NAPELLUS WHOLE9 [hp_X]/mL
- POTASSIUM DICHROMATE9 [hp_X]/mL
- AVENA SATIVA FLOWERING TOP12 [hp_X]/mL
- INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]/mL
- INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]/mL
- INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]/mL
- PRATIA PURPURASCENS16 [hp_X]/mL
- CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE16 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE3 [hp_C]/mL
- ZELTNERA VENUSTA WHOLE FLOWERING30 [hp_C]/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75053-0011-1 | 75053001101 | 118 mL in 1 BOTTLE, DROPPER (75053-0011-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 75053-0011 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75053-0011 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75053-0011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.